Treatment of Bacterial Sinusitis in Children

First-Line Antibiotic Selection

• The American Academy of Pediatrics recommends standard-dose amoxicillin at 45 mg/kg/day in 2 divided doses as the first-line treatment for children aged ≥2 years without recent antibiotic exposure, not attending daycare, and with no known drug allergies 1, 2
• For a 16kg child, the dose calculates to 720 mg/day total, given as 360 mg twice daily, which is the recommended dosage by the American Academy of Pediatrics 1, 2
• Amoxicillin remains the antibiotic of choice based on its effectiveness against Streptococcus pneumoniae, safety profile, acceptable taste for children, low cost, and narrow microbiologic spectrum, as recommended by the American Academy of Pediatrics 1

When to Escalate to High-Dose Therapy

• The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses) for children with specific risk factors, such as age <2 years, daycare attendance, antibiotic use within the past 4-6 weeks, or residence in areas with high prevalence (>10%) of resistant S. pneumoniae 1, 2
• Risk factors requiring high-dose therapy include age <2 years, daycare attendance, antibiotic use within the past 4-6 weeks, or residence in areas with high prevalence (>10%) of resistant S. pneumoniae, as identified by the American Academy of Pediatrics 1, 2

Treatment Duration

• The American Academy of Pediatrics recommends treating for a minimum of 10-14 days total, or continuing antibiotics for 7 days after the child becomes symptom-free, with a strength of evidence rated as high 1, 3
• This individualized approach ensures at least 10 days of treatment while avoiding prolonged therapy in asymptomatic patients who are unlikely to adhere to the full course, as recommended by the American Academy of Pediatrics and the American Family Physician 1, 3

Critical 72-Hour Reassessment

• The American Academy of Pediatrics recommends reassessing the child at 72 hours: if symptoms are worsening or failing to improve, switch to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component), with a strength of evidence rated as moderate 1, 2
• Treatment failure at 72 hours suggests β-lactamase-producing organisms (Haemophilus influenzae or Moraxella catarrhalis) that require clavulanate coverage, as identified by the American Academy of Pediatrics 1, 2

Alternative for Vomiting or Non-Compliance

• The American Academy of Pediatrics and the American Family Physician recommend giving ceftriaxone 50 mg/kg IM or IV as a single dose (800 mg for a 16kg child) if the child is vomiting, cannot tolerate oral medications, or is unlikely to take initial antibiotic doses as prescribed, with a strength of evidence rated as high 1, 3
• After clinical improvement with ceftriaxone, switch to oral amoxicillin to complete the 10-14 day course, as recommended by the American Academy of Pediatrics and the American Family Physician 1, 3

Red Flags Requiring Immediate Escalation

• The American Family Physician recommends suspecting orbital or intracranial complications if the child develops periorbital swelling, proptosis, impaired extraocular muscle function, severe headache, altered mental status, seizures, or focal neurologic findings, with a strength of evidence rated as high 3, 4
• These complications require immediate contrast-enhanced CT imaging, IV antibiotics (vancomycin plus ceftriaxone or cefotaxime), and urgent ENT/neurosurgery consultation, as recommended by the American Family Physician 3, 4

Critical Pitfalls to Avoid

• The American Family Physician recommends avoiding the use of azithromycin or trimethoprim-sulfamethoxazole—surveillance studies demonstrate significant resistance of S. pneumoniae and H. influenzae to these agents (20-25% resistance rates), with a strength of evidence rated as high 3, 4
• The American Family Physician also recommends avoiding obtaining imaging (CT or MRI) for uncomplicated bacterial sinusitis—imaging does not contribute to diagnosis in straightforward cases and is reserved only for suspected complications, with a strength of evidence rated as moderate 3, 4

First‑Line Antibiotic Therapy for Pediatric Acute Bacterial Sinusitis

Standard First‑Line Therapy

• Amoxicillin dosed at 45 mg/kg/day divided twice daily is the preferred initial regimen for children ≥ 2 years who have no recent antibiotic exposure, are not in daycare, and have no drug allergies. 5
• The recommended course is a minimum of 10–14 days total, or continuation for 7 days after the child becomes symptom‑free. 5

When to Escalate to High‑Dose Amoxicillin‑Clavulanate

• Switch to high‑dose amoxicillin‑clavulanate (amoxicillin 90 mg/kg/day + clavulanate 6.4 mg/kg/day, divided twice daily) in children who have any of the following risk factors:
  
  • Age < 2 years,
  • Daycare attendance,
  • Antibiotic use within the prior 4–6 weeks,
  • Residence in an area where >10 % of Streptococcus pneumoniae are penicillin‑resistant, or
  • Severe presentation (fever ≥ 39 °C with purulent nasal discharge for ≥ 3 consecutive days). 5

Critical 72‑Hour Reassessment

• Reassess the child 72 hours after initiating antibiotics. 5
• If there is worsening or no improvement, change immediately to high‑dose amoxicillin‑clavulanate (amoxicillin 90 mg/kg/day). 5
• Failure to reassess and adjust therapy at 72 hours is a common pitfall that can delay effective treatment. 5

Alternatives for Penicillin Allergy

• For non‑severe (non‑Type I) penicillin allergy, prescribe a second‑ or third‑generation oral cephalosporin (e.g., cefdinir, cefuroxime axetil, or cefpodoxime proxetil) for 10 days. 5
• For severe (Type I/anaphylactic) allergy, consider a fluoroquinolone such as levofloxacin or moxifloxacin, recognizing the usual avoidance of this class in children. 5
• Cross‑reactivity between penicillins and second/third‑generation cephalosporins is negligible, making these agents safe for most penicillin‑allergic children. 5

Special Situations: Vomiting or Non‑Compliance

• Administer a single dose of ceftriaxone 50 mg/kg intramuscularly or intravenously when the child cannot tolerate oral medication. 5

Agents to Avoid as First‑Line Therapy

• Azithromycin and trimethoprim‑sulfamethoxazole should never be used first‑line because resistance rates in S. pneumoniae and H. influenzae exceed 20–25 %. 5
• The American Academy of Pediatrics explicitly contraindicates azithromycin for pediatric sinusitis due to these resistance patterns. 5

Red‑Flag Findings Requiring Immediate Escalation

• Suspect orbital or intracranial complications if the child develops any of the following: periorbital swelling, proptosis, impaired extra‑ocular muscle function, severe headache, altered mental status, seizures, or focal neurologic deficits. 5
• Management includes urgent contrast‑enhanced CT imaging, intravenous antibiotics (vancomycin plus ceftriaxone or cefotaxime), and immediate ENT/neurosurgery consultation. 5

Common Pitfalls to Avoid

• Do not obtain imaging (CT or MRI) for uncomplicated bacterial sinusitis; reserve imaging for suspected complications. 5
• Do not use first‑generation cephalosporins (e.g., cephalexin) because they lack adequate coverage against β‑lactamase‑producing H. influenzae. 5
• Do not continue ineffective therapy beyond 72 hours; early reassessment and appropriate escalation are essential to prevent treatment failure. 5